Despite the comprehensive analysis of the intricate roles of GSH metabolism-related genes in the tumor microenvironment using single-cell and transcriptome data from PC, and the successful in vitro validation of the key target GSTA4, the study has inherent limitations. This evidence concerns the gene GSTA4 and neoplasm.